Paramount is asking states to shoulder the costs of delaying its $111 billion acquisition of Warner Bros. Discovery until a trial scheduled for March. The request adds financing and execution pressure to WBD’s already weak operating profile while the deal remains tied up in court.
Paramount is asking states to shoulder the costs of delaying its $111 billion acquisition of Warner Bros.
The delayed $111 billion transaction moves the near-term risk to the downside for WBD as weak revenue and thin net margins meet a longer court-driven closing timeline.
A favorable court outcome, acceptance of Paramount’s cost request or an accelerated closing timetable would remove the central downside pressure.
CoverageSource: NYT Business · Published here TUE, AUG 18 · 6:01 PM ET · 3 outlets in this record · latest listed: NYT Business at 6:01 PM ETHow this is decided →
STOCK PHOTO · PEW NGUYENThe proposed transaction cannot close before the conclusion of a trial scheduled for March, extending the period in which Paramount and Warner Bros. Discovery remain exposed to legal and deal uncertainty. Paramount is seeking to have states bear the costs associated with the delay, according to The New York Times Business report published August 17.
Warner Bros. Discovery is the named public-company exposure in the story. Its FY 2025 revenue was $37.3B, down 5.1% YoY, with a 1.9% net margin and $0.29 diluted EPS, leaving limited operating cushion as the transaction timeline stretches.
The next markers are the court proceedings, the states’ response to Paramount’s request and any changes to the proposed deal terms or closing timetable. The report does not establish whether the cost request will be accepted or whether the trial will resolve the broader legal challenge.
The delay keeps WBD exposed to deal uncertainty while its FY 2025 revenue fell 5.1% YoY and its net margin was only 1.9%. Paramount’s request to shift delay costs to states signals that the timetable carries a meaningful economic burden, making the March court process the key catalyst.
The read above, as written. kept as written
Into the March trial. Follow to be told when one lands.
The strongest bull case is that the $111 billion transaction ultimately survives the March trial, giving WBD a path to a strategic combination despite its FY 2025 revenue decline.
The bear case is stronger: the postponement extends legal and financing uncertainty for WBD, whose FY 2025 revenue fell 5.1% YoY and net margin was 1.9%, while the report provides no evidence that the delay costs will be shifted successfully.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →